GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SELLAS Life Sciences Group Inc (FRA:RXK3) » Definitions » 6-1 Month Momentum %

SELLAS Life Sciences Group (FRA:RXK3) 6-1 Month Momentum % : 22.75% (As of Jun. 18, 2024)


View and export this data going back to 2008. Start your Free Trial

What is SELLAS Life Sciences Group 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-06-18), SELLAS Life Sciences Group's 6-1 Month Momentum % is 22.75%.

The industry rank for SELLAS Life Sciences Group's 6-1 Month Momentum % or its related term are showing as below:

FRA:RXK3's 6-1 Month Momentum % is ranked better than
76.11% of 1515 companies
in the Biotechnology industry
Industry Median: -5.58 vs FRA:RXK3: 22.75

Competitive Comparison of SELLAS Life Sciences Group's 6-1 Month Momentum %

For the Biotechnology subindustry, SELLAS Life Sciences Group's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SELLAS Life Sciences Group's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SELLAS Life Sciences Group's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where SELLAS Life Sciences Group's 6-1 Month Momentum % falls into.



SELLAS Life Sciences Group  (FRA:RXK3) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SELLAS Life Sciences Group  (FRA:RXK3) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


SELLAS Life Sciences Group 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of SELLAS Life Sciences Group's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


SELLAS Life Sciences Group (FRA:RXK3) Business Description

Traded in Other Exchanges
Address
7 Times Square, Suite 2503, New York, NY, USA, 10036
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

SELLAS Life Sciences Group (FRA:RXK3) Headlines

No Headlines